Concepedia

Chengzhi Yi

CY

Statistics

Publications

7

Citations

180

H-Index

7

Active since

2017

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengzhou University

Wuhan Puai Hospital

Wuhan University

Chengzhi Yi is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, bladder cancer, and molecular oncology.

Publications per year

2017–2023

7

Publications

7

MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1.

Xiaoming Yang, Lei Shi, Chengzhi Yi et al. · PubMed · 2017 · 49 citations

, , +16

Lnc<scp>RNA MBNL</scp>1‐<scp>AS</scp>1 represses cell proliferation and enhances cell apoptosis via targeting miR‐135a‐5p/<scp>PHLPP</scp>2/<scp>FOXO</scp>1 axis in bladder cancer

Xiaosong Wei, Xiaoming Yang, Beibei Wang et al. · Cancer Medicine · 2019 · 35 citations · Full text

, , +17

A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro

Jianhua Liu, Long He, Zhimiao Zou et al. · Kidney & Blood Pressure Research · 2018 · 32 citations · Full text

, , +14

MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI

Xiaosong Wei, Beibei Wang, Qi Wang et al. · Frontiers in Pharmacology · 2020 · 28 citations · Full text

, , +17

Protective effect of omega-3 polyunsaturated fatty acids on sepsis via the AMPK/mTOR pathway

Peng Liu, Ming Li, Wei Wu et al. · Pharmaceutical Biology · 2023 · 13 citations · Full text

, , +17

1–5 of 7